A61K9/2072

TABLET

Provided is a tablet which can be easily pinched even for an elderly person or a patient who has a limited range of joint motion, and which is hard to roll even if slipping out of a hand. The tablet 1 includes a three-dimensional tablet body portion 10 and a protruding portion 20 protruding outward in a longitudinal direction of the tablet body portion 10 continuously from a side surface of the tablet body portion 10. The protruding portion 20 has a first protruding portion 21 and a second protruding portion 22 protruding in opposite directions from each other via the tablet body portion 10. Each of the first protruding portion 21 and the second protruding portion 22 protrudes from the upper portion and the lower portion of the side surface of the tablet body portion 10.

Oral drug delivery system

An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a swellable composition located in an immediate vicinity of one or more preselected surfaces. The coating comprises a defect wherein said defect is not a passageway through the preselected portion of the coating and operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
20190070201 · 2019-03-07 · ·

Compositions and methods for individualized therapy of pain using a non-steroidal anti-inflammatory drug (NSAID) and an anti-hypertensive without inducing intolerable edema. Said methods comprise basing NSAID/anti-hypertensive dose on each patient's pharmacokinetic response to said NSAID.

SOLID DOSAGE FORMS OF VIGABATRIN
20190070138 · 2019-03-07 ·

The invention pertains to a solid dosage form comprising vigabatrin; a superdisintegrant, advantageously chosen from the list consisting of crospovidone, a cellulose derivative and a starch derivative; a non-reducing sugar, advantageously chosen from the list consisting of mannitol, xylitol, and sorbitol; and a stearate derivative, advantageously a stearate or stearyl fumarate salt, more advantageously sodium stearyl fumarate or magnesium stearate.

RAPIDLY DISINTEGRATING TABLET COMPOSITIONS OF DPP-IV INHIBITORS WITH LOW MINERAL CONTENT

A rapidly disintegrating tablet comprising a therapeutically effective amount of a DPP-IV inhibitor and an acid-base couple having mineral content below the daily intake limits is disclosed. The rapidly disintegrating tablet has a sodium content less than 10 mg and a potassium content less than 15 mg. A process for preparation of the rapidly disintegrating tablet comprising the DPP-IV inhibitor is also disclosed.

MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME
20190060277 · 2019-02-28 · ·

The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.

STABILIZED FORMULATIONS OF CNS COMPOUNDS

Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.

ARTICLE AND METHOD FOR A PHARMACEUTICAL AGENT
20190060243 · 2019-02-28 ·

A versatile and effective manner to provide a single tablet or tablet arrangement or other medication delivery system for a combination of medications comprising of two or more active ingredients to be administered by, for example, severing along the score line to separate the active ingredients and to consume each active ingredient separately or in various ratios depending on the applicable pharmaceutical agent that a patient desires to ingest or otherwise administer. In some embodiments, a single tablet comprising of two or more active ingredients is administered by severing along score lines to separate the active ingredients to consume two or more active ingredients in combination. This delivery system provides a variety of alternatives to a consumer for administrating a combination of active ingredients while varying the relevant rations of the active ingredients. Simultaneous administration of medication is also provided by specific inhaler and syringe systems.

Oral drug delivery system

An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a reactive composition located in an immediate vicinity of one or more preselected surfaces. The coating is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

PHARMACEUTICAL COMPOSITION PARTICLES, ORALLY DISINTEGRATING PREPARATION INCLUDING SAME, AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION PARTICLES

Provided are pharmaceutical composition particles which are capable of achieving both of masking of an unpalatable taste and improvement in dissolution properties; an orally disintegrating tablet including the pharmaceutical composition particles; and a method for manufacturing the pharmaceutical composition particles. Each of the pharmaceutical composition particles includes: a drug-containing core particle; an intermediate layer containing a gelling swelling substance and coating an outside of the core particle; and an outermost layer containing a water-insoluble substance and coating an outside of the intermediate layer. In addition, the method for manufacturing the pharmaceutical composition particles includes: a pulverization step of pulverizing the gelling swelling substance so as to have an average particle diameter of 15 m or less; a suspension step of obtaining a suspension by suspending the gelling swelling substance pulverized at the pulverization step in an organic solvent; an intermediate layer formation step of forming an intermediate layer on an outside of a core particle by spraying the suspension obtained at the suspension step onto the core particle containing a drug; and an outer layer formation step of forming an outer layer by coating an outside of the intermediate layer with a water-insoluble substance.